NEW YORK & GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- ANANDA Scientific Inc., a research focused biopharmaceutical company today announced approval by the US Food and Drug Administration (FDA) of the IND application for a clinical trial evaluating Nantheia™ A1002N5S, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary Liquid Structure™ delivery technology as a potential treatment for Social Anxiety Disorder. The National Center for Complimentary and Integrative Health...
Read More